Julia Kaufman

Julia is an Investment Manager with the Boehringer Ingelheim Venture Fund since 2022. She received her Ph.D. in Immunology from the University of Rochester School of Medicine and Dentistry. In 2002, she joined the lab of Molecular Neuro-Oncology at the Rockefeller University. As part of the Translational Immuno-Oncology team, Julia focused on dendritic cell and T cell biology and the development of dendritic cell-based cancer vaccines, which led to successful completion of three Phase 1 clinical studies. In 2014, Julia joined Boehringer Ingelheim Pharmaceuticals Inc. Immunology and Respiratory Disease Research group in Ridgefield, CT, where she served in various roles, such as Laboratory Head, Disease Positioning Lead, and Research Project Leader. During this time, she made significant impact on the Immunology and Respiratory portfolio, including leading cross-functional, global teams to advance two different small molecule programs into early clinical development.